HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of Matrigel on the SF-767 malignant glioma athymic mouse tumor model.

Abstract
Matrigel, an extracellular matrix material, has been used to promote growth of experimental tumors. SF-767, a human glioblastoma cell line, is used in brain tumor research. We investigated Matrigel induced changes in tumor latency, growth rate, cell yield, plating efficiency, and histology of SF-767 tumors in athymic mice. Low volume (0.1 ml) Matrigel did not increase growth rate in comparison with control tumors but appeared to promote uniformity in growth. High volume (0.5 ml) Matrigel increased the initial rate of tumor growth, increased cell yield and produced tumors with a centralized area of residual Matrigel and necrotic cells, with viable cells on the periphery of the mass. On average, tumors grown with Matrigel had shorter latency periods and lower plating efficiencies. We conclude that important characteristics of the SF-767 tumor model, which may be important when evaluating efficacy of anticancer agents, are altered by Matrigel.
AuthorsB J Wyrick, T Ozawa, K R Lamborn, A W Bollen, D F Deen
JournalAnticancer research (Anticancer Res) 1997 Jul-Aug Vol. 17 Issue 4A Pg. 2419-25 ISSN: 0250-7005 [Print] Greece
PMID9252657 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Drug Combinations
  • Laminin
  • Proteoglycans
  • matrigel
  • Collagen
Topics
  • Animals
  • Cell Division
  • Collagen (pharmacology)
  • Drug Combinations
  • Extracellular Matrix (physiology)
  • Glioblastoma (pathology)
  • Humans
  • Laminin (pharmacology)
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Neoplasms, Experimental (pathology)
  • Proteoglycans (pharmacology)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: